|
Q |
Bp197 |
Blood pressure QTL 197 |
|
IEA |
|
RGD |
PMID:8528250 |
RGD:61060 |
NCBI chr 1:168,063,662...213,063,662
|
|
Q |
Bp283 |
Blood pressure QTL 283 |
|
IEA |
|
RGD |
PMID:11053483 |
RGD:70856 |
|
|
Q |
BpQTLcluster14 |
Blood pressure QTL cluster 14 |
|
IEA |
|
RGD |
PMID:10779487 |
RGD:68932 |
NCBI chr17:8,574,342...32,199,534
|
|
Q |
Cia10 |
Collagen induced arthritis QTL 10 |
|
IEA |
|
RGD |
PMID:9870869 |
RGD:61063 |
NCBI chr 2:182,635,347...227,635,347
|
|
Q |
Cia9 |
Collagen induced arthritis QTL 9 |
|
IEA |
|
RGD |
PMID:9870869 |
RGD:61063 |
|
|
Q |
Eae12 |
Experimental allergic encephalomyelitis QTL 12 |
|
IEA |
|
RGD |
PMID:10545597 |
RGD:69695 |
NCBI chr10:73,599,825...107,713,808
|
|
Q |
Eae13 |
Experimental allergic encephalomyelitis QTL 13 |
|
IEA |
|
RGD |
PMID:10545597 |
RGD:69695 |
NCBI chr12:29,775,522...42,298,555
|
|
Q |
Eae14 |
Experimental allergic encephalomyelitis QTL 14 |
|
IEA |
|
RGD |
PMID:10545597 |
RGD:69695 |
|
|
Q |
Eae15 |
Experimental allergic encephalomyelitis QTL 15 |
|
IEA |
|
RGD |
PMID:10545597 |
RGD:69695 |
NCBI chr18:79,484,311...84,129,249
|
|
Q |
Gcr1 |
Gastric cancer resistance QTL 1 |
|
IEA |
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr 4:103,834,277...148,834,277
|
|
Q |
Gcr2 |
Gastric cancer resistance QTL 2 |
|
IEA |
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr 3:29,056,275...47,904,329
|
|
Q |
Gcr3 |
Gastric cancer resistance QTL 3 |
|
IEA |
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr16:17,730,818...72,536,785
|
|
Q |
Gcs1 |
Gastric cancer susceptibility QTL1 |
|
IEA |
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr15:82,714,037...106,778,197
|
|
Q |
Rf1 |
Renal disease susceptibility QTL 1 |
|
IEA |
|
RGD |
PMID:8528250 |
RGD:61060 |
|
|
Q |
Rf2 |
Renal disease susceptibility QTL 2 |
|
IEA |
|
RGD |
PMID:8528250 |
RGD:61060 |
NCBI chr 1:142,582,180...153,680,016
|
|
Q |
Rf3 |
Renal disease susceptibility QTL 3 |
|
IEA |
|
RGD |
PMID:11053483 |
RGD:70856 |
|
|
Q |
Rf4 |
Renal disease susceptibility QTL 4 |
|
IEA |
|
RGD |
PMID:11053483 |
RGD:70856 |
|
|
Q |
Rf5 |
Renal disease susceptibility QTL 5 |
|
IEA |
|
RGD |
PMID:11053483 |
RGD:70856 |
|
|
Q |
Swd1 |
Spike wave discharge measurement QTL 1 |
|
IEA |
|
RGD |
PMID:15270755 |
RGD:1302436 |
NCBI chr 9:109,044,573...109,749,900
|
|
Q |
Swd2 |
Spike wave discharge measurement QTL 2 |
|
IEA |
|
RGD |
PMID:15270755 |
RGD:1302436 |
NCBI chr 5:156,396,728...172,190,305
|
|
|
Q |
Leukc1 |
Leukocyte quantity QTL 1 |
|
IEA |
|
RGD |
PMID:16151696 |
RGD:5135221 |
NCBI chr19:61,249,161...74,246,245
|
|
Q |
Leukc2 |
Leukocyte quantity QTL 2 |
|
IEA |
|
RGD |
PMID:16151696 |
RGD:5135221 |
NCBI chr 2:120,039,407...151,869,825
|
|
Q |
Leukc3 |
Leukocyte quantity QTL 3 |
|
IEA |
|
RGD |
PMID:17090969 |
RGD:5135222 |
NCBI chr 1:227,535,119...233,480,676
|
|
|
Q |
Cia25 |
Collagen induced arthritis QTL 25 |
|
IEA |
|
RGD |
PMID:15334486 |
RGD:1285224 |
NCBI chr12:2,747,694...47,747,694
|
|
Q |
Cia26 |
Collagen induced arthritis QTL 26 |
|
IEA |
|
RGD |
PMID:15334486 |
RGD:1285224 |
NCBI chr18:64,383,762...79,484,311
|
|
Q |
Colcr1 |
Colorectal carcinoma resistance QTL 1 |
|
IEA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr 4:8,428,551...30,449,094
|
|
Q |
Colcr2 |
Colorectal carcinoma resistance QTL 2 |
|
IEA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr15:2,315,759...47,315,759
|
|
Q |
Colcr3 |
Colorectal carcinoma resistance QTL 3 |
|
IEA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr18:1...25,022,372
|
|
Q |
Colcr4 |
Colorectal carcinoma resistance QTL4 |
|
IEA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr 6:30,937,632...75,937,632
|
|
Q |
Colcr5 |
Colorectal carcinoma resistance QTL 5 |
|
IEA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr 6:98,944,780...143,944,780
|
|
Q |
Colcr6 |
Colorectal carcinoma resistance QTL 6 |
|
IEA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr15:83,700,787...108,192,169
|
|
Q |
Colcr7 |
Colorectal carcinoma resistance QTL 7 |
|
IEA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr17:2,120,843...22,087,569
|
|
Q |
Colcr8 |
Colorectal carcinoma resistance QTL 8 |
|
IEA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr18:31,990,891...76,990,891
|
|
Q |
Colcr9 |
Colorectal carcinoma resistance QTL 9 |
|
IEA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr20:1...33,724,594
|
|
Q |
Colcs1 |
Colorectal carcinoma susceptibility QTL 1 |
|
IEA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr 5:160,071,170...172,129,029
|
|
Q |
Emca1 |
Estrogen-induced mammary cancer QTL 1 |
|
IEA |
|
RGD |
PMID:15611180 |
RGD:1358124 |
NCBI chr 5:104,262,817...153,890,625
|
|
Q |
Emca2 |
Estrogen-induced mammary cancer QTL 2 |
|
IEA |
|
RGD |
PMID:15611180 |
RGD:1358124 |
NCBI chr18:65,846,447...86,134,022
|
|
Q |
Emca4 |
Estrogen-induced mammary cancer QTL 4 |
|
IEA |
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 7:63,889,858...108,889,858
|
|
Q |
Emca5 |
Estrogen-induced mammary cancer QTL 5 |
|
IEA |
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 3:145,335,553...189,428,310
|
|
Q |
Emca6 |
Estrogen-induced mammary cancer QTL 6 |
|
IEA |
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 4:45,429,709...157,555,683
|
|
Q |
Emca7 |
Estrogen-induced mammary cancer QTL 7 |
|
IEA |
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 6:20,859,430...113,082,285
|
|
Q |
Emca8 |
Estrogen-induced mammary cancer QTL 8 |
|
IEA |
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 5:55,124,766...172,190,305
|
|
Q |
Ept1 |
Estrogen-induced pituitary tumorigenesis QTL 1 |
|
IEA |
|
RGD |
PMID:15687265 |
RGD:1334449 |
NCBI chr 6:1...44,788,383
|
|
Q |
Ept10 |
Estrogen-induced pituitary tumorigenesis QTL 10 |
|
IEA |
|
RGD |
PMID:15687265 |
RGD:1334449 |
|
|
Q |
Ept13 |
Estrogen-induced pituitary tumorigenesis QTL 13 |
|
IEA |
|
RGD |
PMID:15687265 |
RGD:1334449 |
NCBI chr 1:86,622,262...131,622,262
|
|
Q |
Ept2 |
Estrogen-induced pituitary tumorigenesis QTL 2 |
|
IEA |
|
RGD |
PMID:15687265 |
RGD:1334449 |
NCBI chr 3:67,641,995...130,815,812
|
|
Q |
Ept5 |
Estrogen-induced pituitary tumorigenesis QTL 5 |
|
IEA |
|
RGD |
PMID:17876666 |
RGD:1642526 |
NCBI chr 4:100,752,691...179,366,077
|
|
Q |
Ept6 |
Estrogen-induced pituitary tumorigenesis QTL 6 |
|
IEA |
|
RGD |
PMID:15687265 |
RGD:1334449 |
NCBI chr 3:6,556,347...51,556,347
|
|
Q |
Ept7 |
Estrogen-induced pituitary tumorigenesis QTL 7 |
|
IEA |
|
RGD |
PMID:17876666 |
RGD:1642526 |
NCBI chr 7:63,889,858...108,889,858
|
|
Q |
Ept9 |
Estrogen-induced pituitary tumorigenesis QTL 9 |
|
IEA |
|
RGD |
PMID:15687265 |
RGD:1334449 |
NCBI chr10:73,950,353...96,620,293
|
|
Q |
Esta1 |
Estrogen-induced thymic atrophy QTL 1 |
|
IEA |
|
RGD |
PMID:16688534 |
RGD:1579780 |
NCBI chr10:21,833,758...61,843,633
|
|
Q |
Esta2 |
Estrogen-induced thymic atrophy QTL 2 |
|
IEA |
|
RGD |
PMID:16688534 |
RGD:1579780 |
NCBI chr 2:192,287,802...229,609,668
|
|
Q |
Esta3 |
Estrogen-induced thymic atrophy QTL 3 |
|
IEA |
|
RGD |
PMID:16688534 |
RGD:1579780 |
NCBI chr 2:139,067,258...192,287,892
|
|
Q |
Eutr1 |
Estrogen induced uterine response QTL 1 |
|
IEA |
|
RGD |
PMID:16284801 |
RGD:1559292 |
NCBI chr 5:6,922,282...81,330,203
|
|
Q |
Prcr1 |
Prostate cancer resistance QTL 1 |
|
IEA |
|
RGD |
PMID:15805257 |
RGD:1358944 |
NCBI chr 2:114,440,891...159,440,891
|
|
Q |
Prcr2 |
Prostate cancer resistance QTL 2 |
|
IEA |
|
RGD |
PMID:15805257 |
RGD:1358944 |
NCBI chr 1:10,379,492...55,379,492
|
|
Q |
Prcs1 |
Prostate cancer susceptibility QTL 1 |
|
IEA |
|
RGD |
PMID:15805257 |
RGD:1358944 |
NCBI chr19:31,287,532...51,431,640
|
|
Q |
Prcs2 |
Prostate cancer susceptibility QTL 2 |
|
IEA |
|
RGD |
PMID:15805257 |
RGD:1358944 |
NCBI chr20:1...34,066,551
|
|
Q |
Renag1 |
Renal agenesis QTL 1 |
|
IEA |
|
RGD |
PMID:16845468 |
RGD:1580355 |
|
|
Q |
Tescar1 |
Testicular tumor resistance QTL 1 |
|
IEA |
|
RGD |
PMID:15805257 |
RGD:1358944 |
NCBI chr11:34,618,760...79,618,760
|
|